BioSpace News Archive

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced receipt of the Clinical Trial Authorization (CTA) in the UK for the Company’s Cancer Appetite Recovery Study (CAReS).

Bioventus , a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President of Business Development and Strategy. Yamamoto brings nearly 20 years of experience in mergers & acquisitions and business development. He will be responsible for developing an inorganic growth strategy for the company and executing deals that will drive long-term value and further the company’s missio

Responding to an urgent need for medical ventilators for health professionals in Canada, StarFish Medical – Canada’s leading medical device design and development firm – called on NSK to quickly deliver up to 7,500 Monocarrier™ linear actuator assemblies for use in their Winnipeg 2.0 Ventilator.